GlassScriptPhysician profile
Luis A Tejada
NPI 1295707628
$1,351.03
in general payments reported to CMS, 2019-2025
14 companies · $432 in 2025
The $432 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.07 · 2020: $21.83 · 2022: $300 · 2023: $207 · 2024: $372 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,011.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,010.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $368.55 | 2023-2025 | Optis, Coroflow, Freestyle Libre 3 |
| Edwards Lifesciences Corporation | $319.55 | 2019-2023 | Sapien 3 Ultra Resilia |
| Shockwave Medical, INC | $148.45 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Abiomed | $123.31 | 2024 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.29 | 2025 | Jardiance |
| Insulet Corporation | $84.28 | 2025 | Omnipod |
| Boston Scientific Corporation | $53.05 | 2023-2025 | Icefx Cryoablation System |
| Chiesi USA, INC. | $49.20 | 2024 | Mycapssa |
| E.R. Squibb & Sons, L.L.C. | $27.54 | 2025 | Eliquis |
| Medtronic Vascular, INC. | $21.83 | 2020 | |
| Biotronik INC. | $21.01 | 2024 | Orsiro Mission, Nhancer Rx, Recross |
| Terumo Medical Corporation | $17.97 | 2024 | Progreat, Glidewire |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Tejada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.